IndustryCompany release

STAAR Surgical third-quarter sales fall 12% on China comparison; ICL manufacturing for China moves to Switzerland

🇺🇸 Staar Surgical Co (STAA) · Wed 04 Nov 2026

The EVO ICL maker reports lower year-on-year net sales for the quarter ended 2 October 2026 and flags label expansions and upcoming presbyopia trials.

STAAR Surgical (NASDAQ: STAA), maker of the EVO ICL phakic lens for vision correction, has reported third-quarter 2026 results for the period ended 2 October 2026. Net sales fell 12% year on year. The company attributes the decline to a comparison with the prior-year quarter, which was boosted by China deferred revenue.

The headline of the company's announcement also cites net sales of $83.4M, net income of $5.6M and a $50M share buyback in place. The summary on file does not give further detail on these figures, and the full release text was not available for this report.

STAAR said it has completed the move of all manufacturing of ICLs destined for China to Switzerland. It also expects first-in-human trials of a presbyopia product to begin enrolling in the coming months, pending the remaining regulatory authorisations.

The company also pointed to label expansions for the ICL in the US, where the eligible age has been raised to 60, and in Brazil. The summary does not give the Brazilian details or the timing of either change.

What it means for your team

  • Regulatory teams should note that the presbyopia first-in-human trials still depend on outstanding authorisations, so the enrolment timetable is not yet fixed.
  • Quality and supply-chain teams may wish to track the consolidation of China-bound ICL production in Switzerland, which concentrates manufacturing for that market at a single European site.
  • Market-access and commercial teams should read the 12% sales fall in light of the stated China deferred-revenue comparison rather than as a standalone demand signal.
  • The US eligible-age increase to 60 widens the labelled patient population, which is relevant for post-market surveillance and product-use monitoring.

Company's press release (SEC filing): Staar Surgical Co ↗

Article written by VigiEye from the official source (Staar Surgical Co). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →